Works matching DE "MUSCARINIC antagonists"
Results: 932
UPDATES ON THE MANAGEMENT OF URINARY INCONTINENCE.
- Published in:
- World Council of Enterostomal Therapists Journal, 2018, v. 38, n. 2, p. 44
- By:
- Publication type:
- Article
Single-use, reusable catheters show similar urinary tract infection rates: Technique selection should factor in personal preference, ease of use, researcher says.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 10
- By:
- Publication type:
- Article
More than 50% of patients stop botulinum treatment: Treatment discontinuation seen despite improvement after two injections.
- Published in:
- Urology Times, 2018, v. 46, n. 11, p. 10
- By:
- Publication type:
- Article
New Products & Services.
- Published in:
- 2018
- Publication type:
- Product Review
Management of nocturia: An unmet need in LUTS.
- Published in:
- Urology Times, 2018, v. 46, n. 4, p. 24
- By:
- Publication type:
- Article
Are antimuscarinic drugs overused in treating OAB?
- Published in:
- 2017
- Publication type:
- Chart/Diagram/Graph
The Percutaneous Approach.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
Newer OAB agent viable alternative to antimuscarinics.
- Published in:
- Urology Times, 2013, v. 41, n. 6, p. 11
- By:
- Publication type:
- Article
Antimuscarinic decreases nocturnal urgency episodes.
- Published in:
- Urology Times, 2012, v. 40, n. 7, p. 12
- By:
- Publication type:
- Article
Alpha-blocker, antimuscarinic efficacious in male LUTS.
- Published in:
- Urology Times, 2012, v. 40, n. 4, p. 21
- By:
- Publication type:
- Article
Study: Long-term antimuscarinic use in OAB patients is poor.
- Published in:
- Urology Times, 2010, v. 38, n. 1, p. 20
- By:
- Publication type:
- Article
Treat bladder dysfunction in older patients with established agents, but botulinum toxin type A may have a role.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 4, p. 141, doi. 10.1007/s40267-023-00987-1
- By:
- Publication type:
- Article
The Impact of Treatment of Overactive Bladder on Physical Activity Limitations.
- Published in:
- Journal of Women's Health (15409996), 2016, v. 25, n. 8, p. 801, doi. 10.1089/jwh.2015.5643
- By:
- Publication type:
- Article
What Matters About Overactive Bladder Outcomes.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
QMOD: physically meaningful QSAR.
- Published in:
- Journal of Computer-Aided Molecular Design, 2010, v. 24, n. 10, p. 865, doi. 10.1007/s10822-010-9379-8
- By:
- Publication type:
- Article
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 847, doi. 10.1007/s00228-024-03637-1
- By:
- Publication type:
- Article
LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 10, p. 1321, doi. 10.1007/s00228-023-03543-y
- By:
- Publication type:
- Article
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 7, p. 971, doi. 10.1007/s00228-021-03162-5
- By:
- Publication type:
- Article
Association of tiotropium use and the risk of adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 6, p. 795, doi. 10.1007/s00228-020-02853-9
- By:
- Publication type:
- Article
Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 2, p. 193, doi. 10.1007/s00228-017-2359-3
- By:
- Publication type:
- Article
Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1473, doi. 10.1007/s00228-012-1286-6
- By:
- Publication type:
- Article
The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 2, p. 171, doi. 10.1007/s00228-009-0748-y
- By:
- Publication type:
- Article
What is the success of drug treatment in urge urinary incontinence? What should be measured?
- Published in:
- Archives of Gynecology & Obstetrics, 2013, v. 287, n. 3, p. 511, doi. 10.1007/s00404-012-2596-8
- By:
- Publication type:
- Article
Antipsychotic Drug-Like Effects of the Selective M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 7, p. 1578, doi. 10.1038/npp.2014.2
- By:
- Publication type:
- Article
Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 3, p. 395, doi. 10.1007/s41030-023-00234-y
- By:
- Publication type:
- Article
Prescribing Pathways to Triple Therapy: A Multi-Country, Retrospective Observational Study of Adult Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 333, doi. 10.1007/s41030-020-00132-7
- By:
- Publication type:
- Article
Assessment of Patient Experiences with Respimat<sup>®</sup> in Everyday Clinical Practice.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 371, doi. 10.1007/s41030-020-00127-4
- By:
- Publication type:
- Article
Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 2, p. 191, doi. 10.1007/s41030-019-00099-0
- By:
- Publication type:
- Article
Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 2, p. 179, doi. 10.1007/s41030-019-00098-1
- By:
- Publication type:
- Article
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 2, p. 117, doi. 10.1007/s41030-019-00102-8
- By:
- Publication type:
- Article
Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 1, p. 69, doi. 10.1007/s41030-019-0091-0
- By:
- Publication type:
- Article
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 1, p. 23, doi. 10.1007/s41030-019-0090-1
- By:
- Publication type:
- Article
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2020, v. 30, n. 1, p. N.PAG, doi. 10.1038/s41533-020-00205-9
- By:
- Publication type:
- Article
Urodynamic parameter improvements after mirabegron vs. antimuscarinics agents in non-neurogenic overactive bladder: a systematic review and meta-analysis of treatment effect.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 9, p. 3864
- By:
- Publication type:
- Article
Editorial Comment to Efficacy of novel β<sub>3</sub>‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Editorial Comment to Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Long‐term persistence with mirabegron in a real‐world clinical setting.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 5, p. 501, doi. 10.1111/iju.13558
- By:
- Publication type:
- Article
Systematic review and meta‐analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 3, p. 196, doi. 10.1111/iju.13498
- By:
- Publication type:
- Article
Comparison of mirabegron and imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT study).
- Published in:
- International Journal of Urology, 2016, v. 23, n. 12, p. 1016, doi. 10.1111/iju.13231
- By:
- Publication type:
- Article
Long-term prospective study of the persistence of solifenacin succinate in previously untreated Japanese female patients with overactive bladder.
- Published in:
- International Journal of Urology, 2016, v. 23, n. 10, p. 866, doi. 10.1111/iju.13174
- By:
- Publication type:
- Article
Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 6, p. 586, doi. 10.1111/iju.12372
- By:
- Publication type:
- Article
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: Results of a real-life clinical study.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 4, p. 389, doi. 10.1111/iju.12298
- By:
- Publication type:
- Article
Common theme for drugs effective in overactive bladder treatment: Inhibition of afferent signaling from the bladder.
- Published in:
- International Journal of Urology, 2013, v. 20, n. 1, p. 21, doi. 10.1111/j.1442-2042.2012.03196.x
- By:
- Publication type:
- Article
Excitatory effect of propiverine hydrochloride on urethral activity in rats.
- Published in:
- International Journal of Urology, 2012, v. 19, n. 6, p. 575, doi. 10.1111/j.1442-2042.2012.02977.x
- By:
- Publication type:
- Article
Co-administration of an α<sub>1</sub>-blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity.
- Published in:
- International Journal of Urology, 2011, v. 18, n. 12, p. 836, doi. 10.1111/j.1442-2042.2011.02868.x
- By:
- Publication type:
- Article
Editorial Comment from Dr Dmochowski to Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial.
- Published in:
- International Journal of Urology, 2011, v. 18, n. 5, p. 374, doi. 10.1111/j.1442-2042.2011.02740.x
- By:
- Publication type:
- Article
Preparation of Sterically Demanding 2,2-Disubstituted-2-Hydroxy Acids by Enzymatic Hydrolysis.
- Published in:
- Catalysts (2073-4344), 2019, v. 9, n. 2, p. 113, doi. 10.3390/catal9020113
- By:
- Publication type:
- Article
Analytical Method Development & Validation Protocol For Trospium Chloride In Tablet Dosage Form.
- Published in:
- Indo Global Journal of Pharmaceutical Sciences, 2011, v. 1, n. 2, p. 166, doi. 10.35652/igjps.2011.17
- By:
- Publication type:
- Article
Development of a pharmacological evidence‐based anticholinergic burden scale for medications commonly used in older adults.
- Published in:
- Geriatrics & Gerontology International, 2023, v. 23, n. 7, p. 558, doi. 10.1111/ggi.14619
- By:
- Publication type:
- Article
Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
- Published in:
- Geriatrics & Gerontology International, 2019, v. 19, n. 9, p. 913, doi. 10.1111/ggi.13748
- By:
- Publication type:
- Article